These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 19922518)

  • 41. Advances in Data Analysis for Prevention Intervention Research. September 9-10, 1992. Proceedings.
    NIDA Res Monogr; 1994; 142():1-446. PubMed ID: 9304067
    [No Abstract]   [Full Text] [Related]  

  • 42. Clinical Importance Versus Statistical Significance, and Correcting the Scientific Literature.
    Meyr AJ
    J Foot Ankle Surg; 2016; 55(5):903. PubMed ID: 27565059
    [No Abstract]   [Full Text] [Related]  

  • 43. Interaction effect: Are you doing the right thing?
    Garofalo S; Giovagnoli S; Orsoni M; Starita F; Benassi M
    PLoS One; 2022; 17(7):e0271668. PubMed ID: 35857797
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SCIENTIFIC METHOD AND REPRODUCIBILITY OF RESULTS.
    Dingman HF
    Multivariate Behav Res; 1969 Oct; 4(4):517-22. PubMed ID: 26804660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Substance abuse prevention: practical strategies for psychiatrists in the 21st century.
    Selby P; Vaccarino FJ
    World Psychiatry; 2005 Feb; 4(1):32-3. PubMed ID: 16633499
    [No Abstract]   [Full Text] [Related]  

  • 46. Disclosures: Full transparency is required.
    Citrome L
    Int J Clin Pract; 2018 Mar; 72(3):e13097. PubMed ID: 29667776
    [No Abstract]   [Full Text] [Related]  

  • 47. Statistical significance versus practical significance.
    Curtiss FR
    J Manag Care Pharm; 2002; 8(5):404. PubMed ID: 14613413
    [No Abstract]   [Full Text] [Related]  

  • 48. The One and Only Variable That Needs Statistical Significance: Human Quality.
    Michalakis K
    Obes Surg; 2020 Dec; 30(12):5117-5118. PubMed ID: 32495076
    [No Abstract]   [Full Text] [Related]  

  • 49. Drug use prevention projects in schools in Vitória, Brazil: quality analysis and improvement proposals.
    Borloti E; García MVH; Jiménez VS; Sudbrack MFO
    Psicol Reflex Crit; 2017 Jan; 30(1):1. PubMed ID: 32026023
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Systems Approach to Understanding and Improving Research Integrity.
    Gorman DM; Elkins AD; Lawley M
    Sci Eng Ethics; 2019 Feb; 25(1):211-229. PubMed ID: 29071573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Planning for Long-Term Follow-Up: Strategies Learned from Longitudinal Studies.
    Hill KG; Woodward D; Woelfel T; Hawkins JD; Green S
    Prev Sci; 2016 Oct; 17(7):806-18. PubMed ID: 26453453
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Independent Evaluation of Middle School-Based Drug Prevention Curricula: A Systematic Review.
    Flynn AB; Falco M; Hocini S
    JAMA Pediatr; 2015 Nov; 169(11):1046-52. PubMed ID: 26367105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is Project Towards No Drug Abuse (Project TND) an evidence-based drug and violence prevention program? A review and reappraisal of the evaluation studies.
    Gorman DM
    J Prim Prev; 2014 Aug; 35(4):217-32. PubMed ID: 24753017
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A research strategy case study of alcohol and drug prevention by non-governmental organizations in Sweden 2003-2009.
    Eriksson C; Geidne S; Larsson M; Pettersson C
    Subst Abuse Treat Prev Policy; 2011 Apr; 6():8. PubMed ID: 21492442
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention programs in the 21st century: what we do not discuss in public.
    Holder H
    Addiction; 2010 Apr; 105(4):578-81. PubMed ID: 19922518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Seven ways to increase power without increasing N.
    Hansen WB; Collins LM
    NIDA Res Monogr; 1994; 142():184-95. PubMed ID: 9243537
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current challenges faced by efforts to prevent alcohol and other drug problems: lessons from science-to-practice.
    Holder HD
    Drug Alcohol Rev; 2009 Mar; 28(2):99-102. PubMed ID: 19320692
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Meta-analytical issues for prevention intervention research.
    Tobler N
    NIDA Res Monogr; 1994; 142():342-403. PubMed ID: 9243541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Universal school-based substance abuse prevention programs: Modeling targeted mediators and outcomes for adolescent cigarette, alcohol and marijuana use.
    Stephens PC; Sloboda Z; Stephens RC; Teasdale B; Grey SF; Hawthorne RD; Williams J
    Drug Alcohol Depend; 2009 Jun; 102(1-3):19-29. PubMed ID: 19362433
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.